There are higher risks of several major adverse cardiovascular events (MACEs) following intracerebral hemorrhage (ICH), and they include recurrent ICH, ischemic stroke, and myocardial infarction.
LOS ANGELES, CA—Blood pressure control is a problem for patients who survive an intracerebral hemorrhage (ICH) and require antihypertensive medication, and inadequate medical therapy is mostly to ...
Lowering blood pressure for patients with intracerebral hemorrhage (ICH) does not improve functional recovery, a systematic review and meta-analysis shows, although it does reduce hematoma growth in ...
February 23, 2012 (New Orleans, Louisiana) — A subanalysis from a large clinical trial comparing warfarin with rivaroxaban (Xarelto, Bayer/Johnson & Johnson) points to a number of predictors of risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results